This research explores brain stimulation as a safe, low-cost alternative to medication for children with neurological and mental health conditions. Despite promising results across disorders, only a small fraction of studies involve children. The work aims to expand evidence and access, improving global treatment options, especially for low-income populations.

This research investigates asthma’s underlying mechanisms, focusing on airway fibrosis and the extracellular matrix. Using Raman spectroscopy, researchers generate molecular “barcodes” of lung tissue. Artificial intelligence is then applied to analyze complex data, aiming to identify key biological drivers of asthma and move beyond temporary treatments toward deeper understanding and potential long-term solutions.

This research uses wearable data and AI to detect disease earlier by analyzing continuous health signals rather than isolated clinical snapshots. By personalizing models to individual baselines, the system identifies subtle changes linked to conditions like infections, heart issues, and mental health crises, enabling earlier intervention and potentially saving lives.

This research develops targeted radiopharmaceutical therapies for HER2-positive cancers. By attaching radioactive isotopes to trastuzumab, treatment delivers precise radiation to cancer cells, overcoming drug resistance. The work includes creating practical drug kits and aims to improve cancer outcomes by replacing non-specific therapies with highly accurate, targeted interventions.

This research examines historical struggles over who controls medical devices in the United States. Using cases like the open-source “EpiPencil,” it traces twentieth-century conflicts among doctors, engineers, industry, and government. The study challenges linear progress narratives and shows how shifting claims to expertise shape medical technology and authority.

Acute respiratory distress syndrome (ARDS) causes severe breathing failure and kills tens of thousands annually, yet has no effective treatment. This research studies how ARDS disrupts lung surfactant, a critical stabilizing substance in the lungs. By identifying immune-related factors that damage surfactant, the work aims to develop the first targeted therapeutic cure.

Over 100,000 people await organ transplants, yet preservation limits organs to hours. This research uses radio-frequency sensors to rapidly pre-screen cryoprotective chemicals through dielectric fingerprints, reducing testing from days to minutes. Faster identification of effective preservation agents could extend organ viability and save thousands of lives.

The speaker investigates why surgical sutures often fail and explores bio-inspired alternatives. Studying freshwater mussels—experts at sticking to wet surfaces—they analyze adhesive proteins to design stronger, water-compatible tissue adhesives. This research aims to create safer, more reliable surgical closure methods that reduce complications, infections, and reliance on traditional suturing.